(Q33864418)

English

Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease".

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease". (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

allergic rhinitis

1 reference

based on heuristic

inferred from title

author name string

E O Meltzer

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

84

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

176-85; quiz 185-7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma and allergic rhinitis in the same patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of allergic rhinitis on bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

New approaches to anti-inflammatory therapy for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of leukotriene modifiers in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of leukotrienes in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotriene E4 and granulocytic infiltration into asthmatic airways

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of topical applications of budesonide and azelastine on nasal symptoms, eosinophil count and mediator release in atopic patients after nasal allergen challenge during the pollen season

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone mineral density and bone metabolism of prepubertal children with asthma after long-term treatment with inhaled corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of inhaled corticosteroids and the risk of cataracts.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antileukotrienes in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962750-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)62750-0

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33864418&oldid=1612197236"